Description
Technical Information & Resources
Supporting Publications
Lin et al. (2009), Nature Methods
- Foundational paper that describes a three-compound reprogramming platform using Thiazovivin, SB431542 (Cat No. TB46416), and PD0325901 (Cat No. TB27940) that improved human fibroblast iPSC generation efficiency by more than 200-fold and enhanced survival after trypsinization.
- Study identifying Thiazovivin as a small molecule that increases hESC survival after dissociation while maintaining pluripotency, supporting its use in pluripotent stem cell survival and self-renewal workflows.
Valamehr et al. (2012), Scientific Reports
- Study shows a cocktail containing Thiazovivin supported feeder-free, single-cell hiPSC culture by improving viability, plating efficiency, pluripotency maintenance, and reprogramming performance.







